Mphasis stock initiated with Buy rating at UBS on growth recovery potential
Investing.comMonday, September 15, 2025 at 7:53:03 AM
PositiveFinancial Markets

UBS has initiated coverage of Mphasis stock with a Buy rating, highlighting its potential for growth recovery. This positive outlook reflects confidence in the company's future performance.
Editor’s Note: This matters because a Buy rating from a major financial institution like UBS can significantly influence investor sentiment and stock performance. It suggests that Mphasis is well-positioned for recovery and growth, which could attract more investors.
— Curated by the World Pulse Now AI Editorial System